SCHEMBL2334047

SCHEMBL2334047

CCCCCCCCCC[N+](C)(CCC)CCCCCCCCCC

nearest known ligand 0.62

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 10/20 0.62
HTT P42858 1/20 0.60
SLC22A1 O15245 1/20 0.58
ALDH1A1 P00352 1/20 0.55
TP53 P04637 1/20 0.55
CYP3A4 P08684 1/20 0.55
ALOX15 P16050 1/20 0.55
TSHR P16473 1/20 0.55
ALOX12 P18054 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
HIF1A Q16665 1/20 0.55
HSD17B10 Q99714 1/20 0.55
LSS P48449 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3311711 1.00 DNM1 (0.62) DNM1HTTSLC22A1ALDH1A1TP53
SCHEMBL26306438 1.00 DNM1 (0.62) DNM1HTTSLC22A1ALDH1A1TP53
SCHEMBL11862557 1.00 DNM1 (0.62) DNM1HTTSLC22A1ALDH1A1TP53
SCHEMBL26306423 1.00 DNM1 (0.62) DNM1HTTSLC22A1ALDH1A1TP53
SCHEMBL3304006 1.00 DNM1 (0.62) DNM1HTTSLC22A1ALDH1A1TP53
SCHEMBL17345005 1.00 DNM1 (0.62) DNM1HTTSLC22A1ALDH1A1TP53
SCHEMBL3309633 1.00 DNM1 (0.62) DNM1HTTSLC22A1ALDH1A1TP53
SCHEMBL26306429 1.00 DNM1 (0.62) DNM1HTTSLC22A1ALDH1A1TP53
Fluoride Ion SCHEMBL11748121 0.97 DNM1 (0.59) DNM1HTTSLC22A1ALDH1A1TP53
Hydrochloric Acid SCHEMBL11403208 0.97 DNM1 (0.62) DNM1HTTSLC22A1ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295195-A1 ANTIMICROBIAL ORGANOSILANES Tipikos Pharmaceuticals, Inc. (US) 2023-09-21 US disclosed
US-20230295195-A1 ANTIMICROBIAL ORGANOSILANES Tipikos Pharmaceuticals, Inc. (US) 2023-09-21 US disclosed
WO-2021077119-A1 ANTIMICROBIAL ORGANOSILANES TOPIKOS PHARMACEUTICALS, INC. (US) 2021-04-22 WO disclosed
US-10925995-B2 Absorber and absorbent article using the same LIVEDO CORPORATION (JP) 2021-02-23 US disclosed
CN-104125839-B Absorber and the absorbent commodity for having used the absorber 株式会社利卫多公司 2017-09-01 CN disclosed
EP-2817035-B1 ABSORBER AND ABSORBENT ARTICLE USING THE SAME LIVEDO CORP (JP) 2016-01-20 EP disclosed
US-20150024192-A1 ABSORBER AND ABSORBENT ARTICLE USING THE SAME LIVEDO CORPORATION (JP) 2015-01-22 US disclosed
EP-2817035-A1 ABSORBER AND ABSORBENT ARTICLE USING THE SAME Livedo Corporation (JP) 2014-12-31 EP disclosed
CN-104125839-A Absorber and absorbent article using the same LIVEDO CORP 2014-10-29 CN disclosed
WO-2013125216-A1 ABSORBER AND ABSORBENT ARTICLE USING THE SAME LIVEDO CORPORATION (JP) 2013-08-29 WO disclosed
US-8003369-B2 Bacteriolytic agent SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2011-08-23 US disclosed
US-7582694-B2 Antimicrobial lubricant for wood fiber-plastic composites LONZA, INC. (US) 2009-09-01 US disclosed
US-20090143569-A1 BACTERIOLYTIC AGENT SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2009-06-04 US disclosed
EP-1567586-B1 ANTIMICROBIAL LUBRICANT FOR WOOD FIBER-PLASTIC COMPOSITES LONZA AG (US) 2008-01-09 EP disclosed
CN-100349969-C Antimicrobial lubricant for wood fiber-plastic composites LONZA AG (US) 2007-11-21 CN disclosed
EP-1567586-A4 ANTIMICROBIAL LUBRICANT FOR WOOD FIBER-PLASTIC COMPOSITES LONZA AG (US) 2006-08-16 EP disclosed
US-20050256231-A1 Antimicrobial lubricant for wood fiber-plastic composites LONZA INC. (US) 2005-11-17 US disclosed
CN-1688652-A Antimicrobial lubricant for wood fiber-plastic composites LONZA AG (US) 2005-10-26 CN disclosed
EP-1567586-A2 ANTIMICROBIAL LUBRICANT FOR WOOD FIBER-PLASTIC COMPOSITES LONZA INC. (US) 2005-08-31 EP disclosed
WO-2004022846-A2 ANTIMICROBIAL LUBRICANT FOR WOOD FIBER-PLASTIC COMPOSITES LONZA INC. (US) 2004-03-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143569-A1 BACTERIOLYTIC AGENT PRKCH, PRKCA, PRKCI DNM1 1223/4885HTT 4532/4885SLC22A1 2921/4885
US-20230295195-A1 ANTIMICROBIAL ORGANOSILANES ARG1, ACMSD, AAAS DNM1 283/4885HTT 1159/4885SLC22A1 2461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.